Profilo
Sophia Park currently works at X-Body, Inc., as President & Director and Turning Point Therapeutics, Inc., as Director from 2022.
Posizioni attive di Sophia Park
| Società | Posizione | Inizio |
|---|---|---|
| TURG POIN | Director/Board Member | 17/08/2022 |
X-Body, Inc.
 X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA. | President | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA. | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Sophia Park
